Back to company

ABL BIOTEC A/S: Financial statements 2017

CVR: 50811018

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -125,116 and a net result of DKK 1,139,039 compared with DKK 795,892 the year before. Equity amounted to DKK 24,577,622. The solvency ratio was 98.8%. The company had 1 employee in the financial year.

Gross Profit
-125,116 kr.
Profit/Loss
1,139,039 kr.
Equity
24,577,622 kr.
Total Assets
24,864,880 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--125 t.1.1 mio.24.6 mio.1
2016--118 t.796 t.24.5 mio.1
2015--122 t.2.2 mio.24.8 mio.-
2014--100 t.3.8 mio.23.7 mio.-
2013--97 t.2.7 mio.22.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ABL BIOTEC A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

ABL BIOTEC A/S: The 2016 annual report is outMay 24, 2017

ABL BIOTEC A/S has published its annual report for 2016. Gross profit came to DKK -117,780, and the net result was DKK 795,892.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees. In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity amounted to DKK 27,884,586.